uniQure N.V. - Ordinary Shares (NQ:QURE)

47.46 -0.91 (-1.88%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 24, 2026 Add to My Watchlist

Price and Volume

Volume	920,961
Open	48.00
Bid (Size)	46.48 (100)
Ask (Size)	49.60 (200)
Prev. Close	48.37
Today's Range	46.34 - 48.04
52wk Range	8.730 - 71.50
Shares Outstanding	54,865,673
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

uniQure (QURE) Q2 2026 Earnings Call Transcript ↗

August 07, 2026

Gene therapy biotech secures FDA alignment for Huntington's disease BLA submission.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 30, 2026

Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's after-market session. The market value of their outstanding shares is at $297.1 million. uniQure...

Via Benzinga

Performance

YTD	+102.9%	+102.9%
1 Month	+24.2%	+24.2%
3 Month	+88.7%	+88.7%
6 Month	+94.0%	+94.0%
1 Year	+205.2%	+205.2%

More News

uniQure Q2 Earnings Call Highlights ↗

July 29, 2026

Via MarketBeat

UniQure (NASDAQ:QURE) Rises on Pipeline Progress Despite Wider Q2 Loss ↗

July 29, 2026

Via Chartmill

uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update

July 29, 2026

From uniQure Inc.

Via GlobeNewswire

uniQure to Announce Second Quarter 2026 Financial Results

July 22, 2026

From uniQure Inc.

Via GlobeNewswire

uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares

June 25, 2026

From uniQure Inc.

Via GlobeNewswire

uniQure Announces Pricing of Upsized $225 Million Public Offering

June 23, 2026

From uniQure Inc.

Via GlobeNewswire

uniQure Announces $150 Million Proposed Public Offering

June 22, 2026

From uniQure Inc.

Via GlobeNewswire

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now ↗

June 19, 2026

Via InvestorPlace

uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy

June 19, 2026

From uniQure Inc.

Via GlobeNewswire

Top movers in Wednesday's session ↗

June 17, 2026

Via Chartmill

These stocks are moving in today's session ↗

June 17, 2026

Via Chartmill

Gapping stocks in Wednesday's session ↗

June 17, 2026

Via Chartmill

Discover the top movers in Wednesday's pre-market session. ↗

June 17, 2026

Via Chartmill

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

June 17, 2026

From uniQure Inc.

Via GlobeNewswire

uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates

May 05, 2026

From uniQure Inc.

Via GlobeNewswire

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease

April 30, 2026

From uniQure Inc.

Via GlobeNewswire

uniQure to Announce First Quarter 2026 Financial Results

April 28, 2026

From uniQure Inc.

Via GlobeNewswire

QURE CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026

April 13, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm

April 13, 2026

From Schall Law

Via GlobeNewswire

uniQure N.V. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against uniQure N.V. - QURE

April 10, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

QURE Deadline: Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

April 10, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

UNIQURE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th

April 10, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE

April 09, 2026

From SkyMedia, LLC

Via GlobeNewswire

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?

Yes, uniQure N.V. - Ordinary Shares is publicly traded.

What exchange does uniQure N.V. - Ordinary Shares trade on?

uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for uniQure N.V. - Ordinary Shares?

The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market

What is the current price of uniQure N.V. - Ordinary Shares?

The current price of uniQure N.V. - Ordinary Shares is 47.46

When was uniQure N.V. - Ordinary Shares last traded?

The last trade of uniQure N.V. - Ordinary Shares was at 08/24/26 04:00 PM ET

What is the market capitalization of uniQure N.V. - Ordinary Shares?

The market capitalization of uniQure N.V. - Ordinary Shares is 2.60B

How many shares of uniQure N.V. - Ordinary Shares are outstanding?

uniQure N.V. - Ordinary Shares has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.